$AUSI
AURA SYSTEMS INC Stock $ausi

$ausi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024003660 Filed on January 16, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$56.00K	$47.00K
YoY Change	8932.26%	-12.59%
Cost Of Revenue	$70.00K	$99.00K
YoY Change	117.59%	280.43%
Gross Profit	-$14.00K	-$52.00K
YoY Change	-55.63%	-287.43%
Gross Profit Margin	-25.0%	-110.64%
Selling, General & Admin	$1.873M	$494.0K
YoY Change	208.3%	-20.62%
% of Gross Profit
Research & Development	$750.0K	$33.00K
YoY Change	256.58%	-85.58%
% of Gross Profit
Depreciation & Amortization	$26.00K	$27.00K
YoY Change	25.73%	34.46%
% of Gross Profit
Operating Expenses	$2.623M	$527.0K
YoY Change	220.72%	-38.08%
Operating Profit	-$2.637M	-$579.0K
YoY Change	210.45%	-29.68%
Interest Expense	-$1.456M	$332.0K
YoY Change	-7113.49%	27.54%
% of Operating Profit
Other Income/Expense, Net	$441.0K
YoY Change	44000.0%
Pretax Income	-$4.216M	-$910.0K
YoY Change	409.4%	-28.02%
Income Tax
% Of Pretax Income
Net Earnings	-$4.216M	-$910.0K
YoY Change	409.4%	-28.02%
Net Earnings / Revenue	-7528.57%	-1936.17%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	-$0.04	-$0.01
COMMON SHARES
Basic Shares Outstanding	102.0M shares	100.3M shares
Diluted Shares Outstanding		100.4M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$124.0K	$45.00K
YoY Change	726.67%	-80.76%
Cash & Equivalents	$124.0K	$45.00K
Short-Term Investments
Other Short-Term Assets	$175.0K	$169.0K
YoY Change	23.24%	-7.31%
Inventory	$20.00K	$47.00K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$319.0K	$261.0K
YoY Change	2.24%	-55.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$378.0K	$405.0K
YoY Change	-18.0%	-15.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.0K	$160.0K
YoY Change	0.0%	0.25%
Total Long-Term Assets	$1.145M	$1.225M
YoY Change	-20.32%	-18.62%
TOTAL ASSETS
Total Short-Term Assets	$319.0K	$261.0K
Total Long-Term Assets	$1.145M	$1.225M
Total Assets	$1.464M	$1.486M
YoY Change	-16.3%	-28.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.625M	$2.496M
YoY Change	13.29%	8.0%
Accrued Expenses	$2.598M	$2.400M
YoY Change	41.97%	39.35%
Deferred Revenue
YoY Change
Short-Term Debt	$4.528M	$4.518M
YoY Change
Long-Term Debt Due	$4.751M	$4.768M
YoY Change	-48.41%	-41.87%
Total Short-Term Liabilities	$15.19M	$14.86M
YoY Change	8.28%	12.93%
LONG-TERM LIABILITIES
Long-Term Debt	$7.374M	$7.389M
YoY Change	0.72%	-11.71%
Other Long-Term Liabilities	$423.0K	$485.0K
YoY Change	-35.91%	-32.11%
Total Long-Term Liabilities	$7.797M	$7.874M
YoY Change	-2.31%	-13.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.19M	$14.86M
Total Long-Term Liabilities	$7.797M	$7.874M
Total Liabilities	$22.98M	$22.73M
YoY Change	4.44%	2.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$479.0M	-$477.9M
YoY Change	0.89%	0.84%
Common Stock	$457.5M	$10.00K
YoY Change	5082900.0%	7.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$21.50M	-$21.25M
YoY Change
Total Liabilities & Shareholders Equity	$1.464M	$1.486M
YoY Change	-16.3%	-28.91%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$4.216M	-$910.0K
YoY Change	409.4%	-28.02%
Depreciation, Depletion And Amortization	$26.00K	$27.00K
YoY Change	25.73%	34.46%
Cash From Operating Activities	-$817.0K	-$646.0K
YoY Change	-5.99%	-14.47%
INVESTING ACTIVITIES
Capital Expenditures	-$1.000K	$23.00K
YoY Change	426.32%	-172.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$1.000K	-$23.00K
YoY Change	426.32%	-27.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	895.0K	662.0K
YoY Change	37.66%	-27.42%
NET CHANGE
Cash From Operating Activities	-817.0K	-646.0K
Cash From Investing Activities	1.000K	-23.00K
Cash From Financing Activities	895.0K	662.0K
Net Change In Cash	79.00K	-7.000K
YoY Change	-136.13%	-105.6%
FREE CASH FLOW
Cash From Operating Activities	-$817.0K	-$646.0K
Capital Expenditures	-$1.000K	$23.00K
Free Cash Flow	-$816.0K	-$669.0K
YoY Change	-6.08%	-7.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-11-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	AURA SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4106894
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20431 North Sea Circle
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Forest
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92630
	dei	City Area Code CityAreaCode	(310)
	dei	Local Phone Number LocalPhoneNumber	643-5300
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102008954	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	47000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	155000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	169000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	142000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	261000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	312000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	405000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	461000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	660000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	816000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160000	usd
CY2023Q4	us-gaap	Assets Assets	1486000	usd
CY2023Q1	us-gaap	Assets Assets	1749000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	396000	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	376000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2496000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2758000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1898000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	995000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2400000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471000	usd
CY2023Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	447000	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	454000	usd
CY2023Q1	ausi	Convertible Notes Payables ConvertibleNotesPayables	1403000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1498000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1403000	usd
CY2023Q1	ausi	Convertible Note Payablerelated Party ConvertibleNotePayablerelatedParty	3000000	usd
CY2023Q4	ausi	Convertible Note Payablesrelated Party Past Due ConvertibleNotePayablesrelatedPartyPastDue	3020000	usd
CY2023Q1	ausi	Convertible Note Payablesrelated Party Past Due ConvertibleNotePayablesrelatedPartyPastDue	3000000	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	136000	usd
CY2023Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	92000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	230000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	9000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14859000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14026000	usd
CY2023Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	301000	usd
CY2023Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	256000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	485000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	660000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	22733000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	22007000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101242286	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101242286	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94648346	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94648346	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	456688000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	454507000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-477945000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-474774000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21247000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-20258000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1486000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1749000	usd
CY2023Q4	us-gaap	Revenues Revenues	47000	usd
CY2022Q4	us-gaap	Revenues Revenues	54000	usd
	us-gaap	Revenues Revenues	57000	usd
	us-gaap	Revenues Revenues	70000	usd
CY2023Q4	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	32000	usd
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	90000	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	99000	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	194000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	-52000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	28000	usd
	us-gaap	Gross Profit GrossProfit	-137000	usd
	us-gaap	Gross Profit GrossProfit	15000	usd
CY2023Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	29000	usd
CY2022Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	50000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	117000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	119000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	229000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	528000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	640000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	494000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	622000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1344000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2028000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	527000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	851000	usd
	us-gaap	Operating Expenses OperatingExpenses	1872000	usd
	us-gaap	Operating Expenses OperatingExpenses	2668000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-579000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-823000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2009000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2653000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	200000	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	199000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	981000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	324000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	332000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	260000	usd
	us-gaap	Interest Expense InterestExpense	1171000	usd
	us-gaap	Interest Expense InterestExpense	489000	usd
CY2023Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	usd
CY2022Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	181000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-560000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-910000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1264000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3171000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2582000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100396097	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90759938	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98247106	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87433942	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-20258000	usd
CY2023Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	853000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1141000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-20546000	usd
CY2023Q3	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	757000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1120000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-20909000	usd
CY2023Q4	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	567000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-910000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21247000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-21220000	usd
CY2022Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	635000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	1051000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-552000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-20086000	usd
CY2022Q3	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1034000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-766000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-19818000	usd
CY2022Q4	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	932000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1264000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-20150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3171000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2582000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	79000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	57000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	90000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-560000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-18000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-128000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-73000	usd
	ausi	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-156000	usd
	ausi	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-136000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-262000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	583000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	952000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	183000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-7000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	14000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-152000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-133000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2178000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2254000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2177000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2600000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	120000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	66000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	208000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2231000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2392000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	30000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	84000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	234000	usd
	us-gaap	Interest Paid Net InterestPaidNet	160000	usd
	us-gaap	Interest Paid Net InterestPaidNet	128000	usd
	ausi	Note Payable Issued For Software Licensing Agreement NotePayableIssuedForSoftwareLicensingAgreement	155000	usd
	ausi	Fair Value Of Warrants Issued For Note Settlement FairValueOfWarrantsIssuedForNoteSettlement	1051000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3171000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2178000	usd
CY2023Q4	ausi	Shareholder Deficit ShareholderDeficit	21247000	usd
	ausi	Notes Payables NotesPayables	5200000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made for inventory reserve, impairment testing of long-lived assets, the valuation allowance for deferred tax assets, assumptions used in valuing derivative liabilities, assumptions used in valuing share-based compensation, and accruals for potential liabilities. Amounts could materially change in the future. Actual results could differ from those estimates.</span></p>
CY2023Q4	ausi	Account Payable Percentage AccountPayablePercentage	0.10	pure
CY2023Q1	ausi	Account Payable Percentage AccountPayablePercentage	0.10	pure
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	9000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	9000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain February 28, 2023 balances have been reclassified to conform with the November 30, 2023 presentation. In presenting the Company’s balance sheet at February 28, 2023, the Company originally presented accrued interest of $1,389 and accrued payroll and other expenses of $441, totaling $1,830 as a separate line item called Accrued Expenses. In addition, $82 of accrued interest was included in notes payable-related parties, current portion. In presenting the Company’s balance sheet at November 30, 2023, the Company has reclassified the balance of accrued interest of $1,471 as a separate line item, and the balance of accrued payroll and other expenses of $441 as part of accounts payable and accrued expense and reduced notes payable-related parties, current portion by $82.</span></p>
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	1389000	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	441000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1830000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	82000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1471000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	441000	usd
	us-gaap	Increase Decrease In Notes Payable Related Parties Current IncreaseDecreaseInNotesPayableRelatedPartiesCurrent	82000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	5000	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Current AccountsPayableInterestBearingCurrent	8000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	278000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11861038	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17060681	shares
CY2023Q4	ausi	Convertible Notes Payable Current Gross ConvertibleNotesPayableCurrentGross	1503000	usd
CY2023Q1	ausi	Convertible Notes Payable Current Gross ConvertibleNotesPayableCurrentGross	1403000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	1498000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	1403000	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.05	pure
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	60000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	50000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.5
	ausi	Debt Discount DebtDiscount	5000	usd
	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.17
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.5
	ausi	Expected Life ExpectedLife	P1Y6M
CY2023Q4	ausi	Volatility Rate VolatilityRate	1.60	pure
	ausi	Discount Rate DiscountRate	0.05	pure
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	188000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	20000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3020000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3000000	usd
CY2017Q1	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	3000000	usd
CY2023Q1	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	3000000	usd
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	60000	shares
CY2023Q4	us-gaap	Notes Payable NotesPayable	438000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	348000	usd
CY2023Q4	ausi	Total Notes Payable Noncurrent TotalNotesPayableNoncurrent	302000	usd
CY2023Q1	ausi	Total Notes Payable Noncurrent TotalNotesPayableNoncurrent	256000	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	136000	usd
CY2023Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	92000	usd
CY2020Q3	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	150000	usd
CY2020Q3	srt	Interest Earning Assets Net Yield InterestEarningAssetsNetYield	0.0375	pure
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	155000	usd
CY2023Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2023Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	11720000	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	11697000	usd
CY2022Q1	ausi	Aggregate Amount AggregateAmount	1000000	usd
CY2022Q2	ausi	Installment Paid InstallmentPaid	150000	usd
CY2022Q2	ausi	Installment Outstanding InstallmentOutstanding	2850000	usd
CY2023Q1	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.06	pure
CY2023Q4	ausi	Incurred Extension And Forbearance Fees incurredExtensionAndForbearanceFees	390000	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	23000	usd
CY2023Q4	ausi	Outstanding Principal Balance Amount OutstandingPrincipalBalanceAmount	10938000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3850000	usd
	ausi	Initial Payment InitialPayment	2850000	usd
	ausi	Installment Paid InstallmentPaid	1000000	usd
CY2014Q2	ausi	Bears Interest Rate BearsInterestRate	0.10	pure
CY2023Q1	ausi	Notes Payable And Accrued Interest NotesPayableAndAccruedInterest	700000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	408000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	354000	usd
CY2023Q4	ausi	Accrued Interestconvertible Notes Payable Related Party AccruedInterestconvertibleNotesPayableRelatedParty	826000	usd
CY2023Q1	ausi	Accrued Interestconvertible Notes Payable Related Party AccruedInterestconvertibleNotesPayableRelatedParty	713000	usd
CY2023Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	1145000	usd
CY2023Q1	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	364000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	21000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	23000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	17000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2400000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471000	usd
	ausi	Square Foot SquareFoot	18000	sqft
	ausi	Lease Rent Percentage LeaseRentPercentage	0.03	pure
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	209000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	209000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	212000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	206000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q4	ausi	Longterm Rightofuse Assets LongtermRightofuseAssets	660000	usd
CY2023Q4	ausi	Shortterm Operating Lease Liabilities ShorttermOperatingLeaseLiabilities	230000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	485000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	715000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	70000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	291000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	154000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	815000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	100000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	715000	usd
CY2023Q1	ausi	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber	3564764	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.86
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	60000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4792857	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	542857	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.4
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4250000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.37
CY2023Q4	ausi	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber	3624764	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.85
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.85
CY2022Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	1051000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.85
CY2022Q4	us-gaap	Share Price SharePrice	0.317
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.25	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0198	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Interest Costs Incurred InterestCostsIncurred	117000	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	119000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	222000	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	223000	usd
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	238000	usd
CY2021Q3	us-gaap	Principal Amount Outstanding On Loans Held For Sale Or Securitization PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization	330000	usd
	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	318000	usd
CY2023Q4	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	12000	usd
	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	13000000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	23000000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2022Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3000000	usd
CY2022Q2	us-gaap	Derivative Premium Paid DerivativePremiumPaid	150000	usd
CY2019Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	27500000	usd
CY2023Q4	ausi	Principal Amount PrincipalAmount	82000	usd
CY2023Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	766668	shares
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	253000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023Q4	ausi	Convertible Notes Payables ConvertibleNotesPayables		usd
CY2023Q4	ausi	Convertible Note Payablerelated Party ConvertibleNotePayablerelatedParty		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87433942	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90759938	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98247106	shares
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	ausi	Note Payable Issued For Software Licensing Agreement NotePayableIssuedForSoftwareLicensingAgreement		usd
	ausi	Fair Value Of Warrants Issued For Note Settlement FairValueOfWarrantsIssuedForNoteSettlement		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities		usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	ausi	Granted Weighted Average Intrinsic Value GrantedWeightedAverageIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	ausi	Cancelled Weighted Average Intrinsic Value CancelledWeightedAverageIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000826253
	dei	Entity File Number EntityFileNumber	000-17249

Files In Submission

Name	View Source	Status
0001213900-24-003660-index-headers.html	Edgar Link	pending
0001213900-24-003660-index.html	Edgar Link	pending
0001213900-24-003660.txt	Edgar Link	pending
0001213900-24-003660-xbrl.zip	Edgar Link	pending
ausi-20231130.xsd	Edgar Link	pending
f10q1123ex31-1_aurasystems.htm	Edgar Link	pending
f10q1123ex31-2_aurasystems.htm	Edgar Link	pending
f10q1123ex32-1_aurasystems.htm	Edgar Link	pending
f10q1123_aurasys.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
ausi-20231130_lab.xml	Edgar Link	unprocessable
ausi-20231130_pre.xml	Edgar Link	unprocessable
ausi-20231130_cal.xml	Edgar Link	unprocessable
ausi-20231130_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q1123_aurasys_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUSI
AURA SYSTEMS INC Stock $ausi

2024 Q1 Form 10-Q Financial Statement

#000121390024003660 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUSI AURA SYSTEMS INC Stock $ausi

2024 Q1 Form 10-Q Financial Statement

#000121390024003660 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUSI
AURA SYSTEMS INC Stock $ausi